Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Household income is associated with functional outcomes in a multi-institutional cohort of patients with ischemic stroke and COVID-19.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2023
Same author

Challenging Cases in Neurology Introduction.

Seminars in neurology·2023
Same author

Antithrombotic Therapy in Patients With Cerebral Microbleeds or Cortical Siderosis: Is This Contraindicated?

Neurology·2022
Same author

Case report and review of literature: Isolated intramedullary spinal neurocysticercosis.

Frontiers in neurology·2022
Same author

Recent advances in the management of transient ischemic attacks.

Faculty reviews·2022
Same author

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee.

Neurology·2022
Same journal

Associations of neuropathic pain and pain catastrophizing with rehabilitation outcomes in patients with stroke.

Topics in stroke rehabilitation·2026
Same journal

Education level amplifies the mediating pathway of rehabilitation motivation between metacognition and quality of life in stroke survivors.

Topics in stroke rehabilitation·2026
Same journal

Cortical activation and functional connectivity during thumb-to-finger opposition in patients with stroke with varying functional levels: insights from fNIRS.

Topics in stroke rehabilitation·2026
Same journal

Cognitive strategies for improving activity-level outcomes post stroke: an integrative review.

Topics in stroke rehabilitation·2026
Same journal

Efficacy of repetitive transcranial magnetic stimulation combined with soft robotic glove training for slight-to-moderate post-stroke upper limb spasticity: a randomized controlled trial.

Topics in stroke rehabilitation·2026
Same journal

Common coping and collaborative management of stroke survivors' spousal caregivers: a moderated mediation model of illness perception and resilience.

Topics in stroke rehabilitation·2026
See all related articles

Related Experiment Video

Updated: Jul 7, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

Vascular dementia.

Michael J Schneck1

  • 1Neurology and Neurosurgery, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.

Topics in Stroke Rehabilitation
|February 6, 2008
PubMed
Summary
This summary is machine-generated.

Vascular dementia (VaD) involves executive function loss due to brain infarction or hemorrhage. Cardiovascular risk reduction is key, with donepezil showing the most robust data among potential treatments.

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Experiment Videos

Last Updated: Jul 7, 2026

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on: May 17, 2024

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Vascular dementia (VaD) is the second most prevalent dementia type, following Alzheimer's dementia (AD).
  • VaD is characterized by executive dysfunction and less severe memory impairment than AD.
  • It is linked to cerebrovascular events like infarction or hemorrhage.

Purpose of the Study:

  • To summarize the current understanding of Vascular Dementia.
  • To highlight treatment strategies and the evidence supporting them.

Main Methods:

  • Review of existing literature on Vascular Dementia.
  • Analysis of treatment efficacy data, focusing on pharmacological interventions.

Main Results:

  • Cardiovascular risk factor reduction is the primary treatment approach for VaD.
  • Anticholinesterase inhibitors and memantine are considered potential therapeutic options.
  • Donepezil demonstrates the most substantial supporting data among these pharmacological treatments.

Conclusions:

  • Management of Vascular Dementia primarily involves addressing vascular risk factors.
  • Pharmacological treatments, particularly donepezil, may offer benefits for symptom management in VaD.